Jadestone Energy Inc (JSE)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 43.00 |
|---|---|
| 52-week range | 20.50 – 45.00 |
| Return, 1 month / 3 months | +11.7% / +38.7% |
| Return, 1 year / 3 years | +77.3% / +45.8% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 40.4% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 59.59M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jadestone Energy is an independent oil and gas company that produces and develops energy assets in the Asia-Pacific region. It operates offshore fields, including the Montara project and the Stag field off Western Australia, and holds interests in other producing and development properties in the region. Its customers are the buyers of crude oil and associated liquids from its operations. The company is based in Singapore and manages a portfolio of upstream oil and gas interests across several countries in the area.
On this site Jadestone Energy Inc appears as a stock on the London Stock Exchange (UK), code JSE, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jadestone Energy Inc (JSE) trades on the London Stock Exchange in UK. It last closed at GBX 43.00 on 27 October 2026.
Its price-based Market X-Ray is 82 out of 100 (a strong price profile), ranking 34 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 77.3% and over the last three months it rose 38.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 41.5% | ||
| From 52-week high | -2.9% | ||
| Momentum | 93 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 38.7% | ||
| 6-month return | 42.1% | ||
| 12-month return, skipping the last month | 58.8% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 59.59M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | +11.7% |
| 3 months | +38.7% |
| 6 months | +42.1% |
| 1 year | +77.3% |
| 3 years | +45.8% |
| 5 years | −49.7% |
Signals
| 50-day / 200-day average | 37.13 / 30.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2022 | GBP 0.0049 |
| 16 Jun 2022 | GBP 0.0107 |
| 16 Sep 2021 | GBP 0.0043 |
| 17 Jun 2021 | GBP 0.0077 |
| 15 Oct 2020 | GBP 0.0042 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.